Furthermore, CSP I-plus modified rEndostatin (rES-CSP) also improved the accumulation in liver and HCC tissue, and signifcantly enhanced the inhibitory effects on tumor growth in nude mice with subcutaneous and orthotopic xenograft models of hepatocellular carcinoma HepG2 [21]. This evidence concerns the gene DNAJC5 and neoplasm.